Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorAdan, Aysun
dc.contributor.authorKiraz, Yagmur
dc.contributor.authorBaran, Yusuf
dc.date.accessioned2021-10-09T09:49:22Z
dc.date.available2021-10-09T09:49:22Z
dc.date.issued2016en_US
dc.identifier.issn1389-2010
dc.identifier.issn1873-4316
dc.identifier.otherPubMed ID27604355
dc.identifier.urihttps //doi.org/10.2174/1389201017666160808160513
dc.identifier.urihttps://hdl.handle.net/20.500.12573/980
dc.description.abstractCell viability is defined as the number of healthy cells in a sample and proliferation of cells is a vital indicator for understanding the mechanisms in action of certain genes, proteins and pathways involved cell survival or death after exposing to toxic agents. Generally, methods used to determine viability are also common for the detection of cell proliferation. Cell cytotoxicity and proliferation assays are generally used for drug screening to detect whether the test molecules have effects on cell proliferation or display direct cytotoxic effects. Regardless of the type of cell-based assay being used, it is important to know how many viable cells are remaining at the end of the experiment. There are a variety of assay methods based on various cell functions such as enzyme activity, cell membrane permeability, cell adherence, ATP production, co-enzyme production, and nucleotide uptake activity. These methods could be basically classified into different categories: (I) dye exclusion methods such as trypan blue dye exclusion assay, (II) methods based on metabolic activity, (III) ATP assay, (IV) sulforhodamine B assay, (V) protease viability marker assay, (VI) clonogenic cell survival assay, (VII) DNA synthesis cell proliferation assays and (V) raman micro-spectroscopy. In order to choose the optimal viability assay, the cell type, applied culture conditions, and the specific questions being asked should be considered in detail. This particular review aims to provide an overview of common cell proliferation and cytotoxicity assays together with their own advantages and disadvantages, their methodologies, comparisons and intended purposes.en_US
dc.language.isoengen_US
dc.publisherBENTHAM SCIENCE PUBL LTDEXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATESen_US
dc.relation.isversionof10.2174/1389201017666160808160513en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectviabilityen_US
dc.subjecttetrazoliumen_US
dc.subjectraman-microspectroscopyen_US
dc.subjectKi-67en_US
dc.subjectcytotoxicityen_US
dc.subjectAlamar blueen_US
dc.titleCell Proliferation and Cytotoxicity Assaysen_US
dc.typereviewen_US
dc.contributor.departmentAGÜ, Yaşam ve Doğa Bilimleri Fakültesi, Moleküler Biyoloji ve Genetik Bölümüen_US
dc.contributor.institutionauthorAdan, Aysun
dc.contributor.institutionauthorKiraz, Yagmur
dc.contributor.institutionauthorBaran, Yusuf
dc.identifier.volumeVolume 17 Issue 14 Page 1213-1221en_US
dc.relation.journalCURRENT PHARMACEUTICAL BIOTECHNOLOGYen_US
dc.relation.publicationcategoryDiğeren_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster